Kamada (KMDA) Long-Term Deferred Tax (2018 - 2025)
Kamada's (KMDA) quarterly Long-Term Deferred Tax came in at $1.7 million in Q4 2025, up 238.32% YoY from $488000.0 in Q4 2024, and up 238.32% on a QoQ basis from $488000.0 in Q4 2024.
Kamada (KMDA) Long-Term Deferred Tax (2018 - 2025) Analysis & Trends
Kamada (KMDA) has 5 years of Long-Term Deferred Tax data on file, last reported at $1.7 million in Q4 2025.
- Quarterly Long-Term Deferred Tax rose 238.32% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (up 238.32% YoY) and the FY2025 annual result came in at $1.7 million, up 238.32% from the prior year.
- Long-Term Deferred Tax grew to $1.7 million in Q4 2025, from $488000.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $1.7 million in Q4 2025 to a low of $488000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 488,000.00 |
| Sep 30, 2020 | 298,000.00 |
| Mar 31, 2020 | 421,000.00 |
| Dec 31, 2019 | 1.31 Mn |
| Dec 31, 2018 | 2.05 Mn |